We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients. The trial was approved by the Istituto Superiore di Sanità and the competent Ethics Committees and was monitored by an external Safety Board.
Human neural stem cell transplantation in ALS: initial results from a phase I trial
MASIERO, STEFANO;CIMA, VALENTINA;GAIANI, ALESSANDRA;SORARU', GIANNI;
2015
Abstract
We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients. The trial was approved by the Istituto Superiore di Sanità and the competent Ethics Committees and was monitored by an external Safety Board.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
mazzini.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
3.26 MB
Formato
Adobe PDF
|
3.26 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.